Related Experiment Video
Updated: Dec 14, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
HIV and COVID-19: Intersecting Epidemics With Many Unknowns
Insights
People with HIV (PLWH) may face higher COVID-19 risks due to health disparities and comorbidities. Further research is needed to distinguish HIV
Area of Science:
- Public Health and Epidemiology
- Infectious Diseases
- HIV Medicine
Background:
- The impact of COVID-19 on people living with HIV (PLWH) remains unclear six months into the pandemic.
- Existing data on COVID-19 risk in PLWH are contradictory, necessitating further investigation.
- HIV is a complex condition, and its role as a COVID-19 risk factor requires precise definition.
Purpose of the Study:
- To analyze the disproportionate burden of COVID-19 among PLWH.
- To differentiate between the unadjusted disease burden and excess COVID-19 risk due to HIV's biological effects.
- To understand the impact of public health interventions on PLWH.
Main Methods:
- Review of existing epidemiological data on COVID-19 and HIV.
- Analysis of comorbidities and structural vulnerabilities in PLWH.
- Assessment of the impact of physical distancing on healthcare access for PLWH.
Main Results:
- Apparent risk of COVID-19 appears similar in people with and without HIV, but data are inconsistent.
- PLWH experience higher rates of comorbidities like substance use and mental health disorders, potentially increasing COVID-19 risk.
- The pandemic's restrictions may affect access to essential medical, mental health, and substance use treatments for PLWH.
Conclusions:
- Future studies must differentiate between the overall disease burden in PLWH and excess risk attributable to HIV.
- Structural vulnerabilities and comorbidities significantly influence COVID-19 risk for PLWH.
- Adapting healthcare delivery, including telemedicine, is crucial for maintaining treatment access for PLWH during the pandemic.
Abstract:
As of July 2020, approximately 6 months into the pandemic of novel coronavirus disease 2019 (COVID-19), whether people living with human immunodeficiency virus (HIV; PLWH) are disproportionately affected remains an unanswered question. Thus far, risk of COVID-19 in people with and without HIV appears similar, but data are sometimes contradictory. Some uncertainty is due to the recency of the emergence of COVID-19 and sparsity of data; some is due to imprecision about what it means for HIV to be a "risk factor" for COVID-19. Forthcoming studies on the risk of COVID-19 to PLWH should differentiate between 1) the unadjusted, excess burden of disease among PLWH to inform surveillance efforts and 2) any excess risk of COVID-19 among PLWH due to biological effects of HIV, independent of comorbidities that confound rather than mediate this effect. PLWH bear a disproportionate burden of alcohol, other drug use, and mental health disorders, as well as other structural vulnerabilities, which might increase their risk of COVID-19. In addition to any direct effects of COVID-19 on the health of PLWH, we need to understand how physical distancing restrictions affect secondary health outcomes and the need for, accessibility of, and impact of alternative modalities of providing ongoing medical, mental health, and substance use treatment that comply with physical distancing restrictions (e.g., telemedicine).
More Related Videos
Related Concept Videos
Sexually Transmitted Infections
Viral Recombination
Confounding in Epidemiological Studies
Causality in Epidemiology
Retrovirus Life Cycles
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

